Diagnostic values of cerebrospinal fluid t-tau and Aβ(42) using Meso Scale Discovery assays for Alzheimer’s disease

BACKGROUND: Meso Scale Discovery (MSD) recently established electrochemiluminescence-based assays to measure cerebrospinal fluid (CSF) levels of total tau (t-tau) and amyloid beta 1–42 peptide (Aβ(42)) that can aid in the diagnosis of Alzheimer’s disease (AD). The goal of this investigation is to in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Alzheimers Dis
Autores principales: Pan, Catherine, Korff, Ané, Galasko, Douglas, Ginghina, Carmen, Peskind, Elaine, Li, Ge, Quinn, Joseph, Montine, Thomas J., Cain, Kevin, Shi, Min, Zhang, Jing
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517668/
https://ncbi.nlm.nih.gov/pubmed/25613100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-143099
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares